{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Diagnostic+test+on+urine+samples", "query": { "intervention": "Diagnostic test on urine samples" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 35, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Diagnostic+test+on+urine+samples&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-30T21:12:05.114Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05501366", "title": "Strategies to Augment Ketosis: Optimization of Ketone Delivery Strategies", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Ketosis" ], "interventions": [ { "name": "Ketone Supplement", "type": "DIETARY_SUPPLEMENT" }, { "name": "Beverage Tolerability Questionnaire (BTQ) and satiety visual analogue scale", "type": "BEHAVIORAL" }, { "name": "Blood Draw", "type": "BIOLOGICAL" }, { "name": "Breath Reading", "type": "OTHER" }, { "name": "Heart Rate Variability", "type": "OTHER" }, { "name": "CGM/CKM", "type": "OTHER" }, { "name": "DXA", "type": "RADIATION" }, { "name": "Urine Analysis", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "BEHAVIORAL", "BIOLOGICAL", "OTHER", "RADIATION" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": "30 Years", "sex": "MALE", "summary": "20 Years to 30 Years · Male only" }, "enrollment_count": 14, "start_date": "2023-06-05", "completion_date": "2027-09", "has_results": false, "last_update_posted_date": "2026-05-29", "last_synced_at": "2026-09-30T21:12:05.114Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05501366" }, { "nct_id": "NCT02118675", "title": "Tanita BIA System Validation", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Body Composition", "Circumference Measurements", "Tissue Thickness Measurements" ], "interventions": [ { "name": "Body Measurements", "type": "OTHER" }, { "name": "Body Composition and Circumference measurements", "type": "OTHER" }, { "name": "Whole Body DXA scan", "type": "OTHER" }, { "name": "Bioelectrical Impedance Analysis (BIA)", "type": "OTHER" }, { "name": "BodPod", "type": "OTHER" }, { "name": "Circumferences", "type": "OTHER" }, { "name": "Ultrasound", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Pennington Biomedical Research Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "5 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "5 Years to 80 Years" }, "enrollment_count": 150, "start_date": "2014-01", "completion_date": "2015-12", "has_results": false, "last_update_posted_date": "2017-05-05", "last_synced_at": "2026-09-30T21:12:05.114Z", "location_count": 1, "location_summary": "Baton Rouge, Louisiana", "locations": [ { "city": "Baton Rouge", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02118675" }, { "nct_id": "NCT04002531", "title": "A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Quality of Life", "Renal Insufficiency", "Cardiac Event" ], "interventions": [ { "name": "General and Neurological examination", "type": "OTHER" }, { "name": "Vital signs", "type": "OTHER" }, { "name": "12 lead electrocardiogram", "type": "PROCEDURE" }, { "name": "Echocardiogram", "type": "PROCEDURE" }, { "name": "Blood draw", "type": "PROCEDURE" }, { "name": "Urine collection", "type": "PROCEDURE" }, { "name": "2-hour Holter Monitor", "type": "PROCEDURE" }, { "name": "Brief Pain Inventory questionnaire", "type": "OTHER" }, { "name": "Quality of Life questionnaire", "type": "OTHER" } ], "intervention_types": [ "OTHER", "PROCEDURE" ], "sponsor": "Baylor Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5, "start_date": "2018-11-10", "completion_date": "2019-12-13", "has_results": false, "last_update_posted_date": "2026-03-04", "last_synced_at": "2026-09-30T21:12:05.114Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04002531" }, { "nct_id": "NCT05828069", "title": "A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Recurrent Langerhans Cell Histiocytosis", "Refractory Langerhans Cell Histiocytosis" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Marrow Aspiration", "type": "PROCEDURE" }, { "name": "Bone Marrow Biopsy", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Echocardiography Test", "type": "PROCEDURE" }, { "name": "FDG-Positron Emission Tomography and Computed Tomography Scan", "type": "PROCEDURE" }, { "name": "Lumbar Puncture", "type": "PROCEDURE" }, { "name": "Multigated Acquisition Scan", "type": "PROCEDURE" }, { "name": "Tovorafenib", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "180 Days", "maximum_age": "22 Years", "sex": "ALL", "summary": "180 Days to 22 Years" }, "enrollment_count": 48, "start_date": "2024-03-28", "completion_date": "2028-09-30", "has_results": false, "last_update_posted_date": "2026-09-29", "last_synced_at": "2026-09-30T21:12:05.114Z", "location_count": 107, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Downey, California + 84 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Downey", "state": "California" }, { "city": "Loma Linda", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05828069" }, { "nct_id": "NCT05411081", "title": "Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metastatic Papillary Renal Cell Carcinoma", "Stage IV Renal Cell Cancer AJCC v8" ], "interventions": [ { "name": "Atezolizumab", "type": "BIOLOGICAL" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Scan", "type": "PROCEDURE" }, { "name": "Cabozantinib S-malate", "type": "DRUG" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" } ], "intervention_types": [ "BIOLOGICAL", "PROCEDURE", "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2023-03-24", "completion_date": "2027-07-01", "has_results": false, "last_update_posted_date": "2026-09-03", "last_synced_at": "2026-09-30T21:12:05.114Z", "location_count": 198, "location_summary": "Gilbert, Arizona • Phoenix, Arizona • Little Rock, Arkansas + 157 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Baldwin Park", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05411081" }, { "nct_id": "NCT00591240", "title": "A Biochip for Rapid Diagnosis of Complicated Urinary Tract Infection", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Urinary Tract Infections", "Bladder, Neurogenic" ], "interventions": [], "intervention_types": [], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 338, "start_date": "2007-07", "completion_date": "2011-06", "has_results": true, "last_update_posted_date": "2016-06-27", "last_synced_at": "2026-09-30T21:12:05.114Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00591240" }, { "nct_id": "NCT06951009", "title": "Establishing Baseline Sysmex UF-5000 Flow Cytometer Results in Healthy Men", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Urethritis", "Healthy Men Age 18-50 With no Urethral Symptoms" ], "interventions": [ { "name": "Colli-Pee", "type": "DEVICE" }, { "name": "standard of care 60 mL urine cup", "type": "DEVICE" }, { "name": "Urinalysis", "type": "DIAGNOSTIC_TEST" }, { "name": "Sysmex UP-5000", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DEVICE", "DIAGNOSTIC_TEST" ], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "MALE", "summary": "18 Years to 50 Years · Male only" }, "enrollment_count": 20, "start_date": "2025-04-09", "completion_date": "2025-05-07", "has_results": true, "last_update_posted_date": "2026-08-17", "last_synced_at": "2026-09-30T21:12:05.114Z", "location_count": 1, "location_summary": "Indianapolis, Indiana", "locations": [ { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT06951009" }, { "nct_id": "NCT06600880", "title": "Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer Disease, Early Onset" ], "interventions": [ { "name": "Neuronavigation-guided single-element focused ultrasound transducer", "type": "DEVICE" }, { "name": "Lumason", "type": "DRUG" }, { "name": "Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents", "type": "OTHER" }, { "name": "Positron Emission Tomography (PET)", "type": "RADIATION" }, { "name": "Amyvid", "type": "DRUG" }, { "name": "MK-6240", "type": "DRUG" }, { "name": "Dotarem", "type": "DRUG" }, { "name": "Blood draw", "type": "DIAGNOSTIC_TEST" }, { "name": "UR5e", "type": "DEVICE" }, { "name": "Urine test", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DEVICE", "DRUG", "OTHER", "RADIATION", "DIAGNOSTIC_TEST" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 6, "start_date": "2027-08", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-05-13", "last_synced_at": "2026-09-30T21:12:05.114Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06600880" }, { "nct_id": "NCT05564390", "title": "MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Myeloid Leukemia", "Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm", "Acute Myeloid Leukemia Post Cytotoxic Therapy", "Acute Myeloid Leukemia, Myelodysplasia-Related", "Myelodysplastic Syndrome" ], "interventions": [ { "name": "Allogeneic Hematopoietic Stem Cell Transplantation", "type": "PROCEDURE" }, { "name": "Azacitidine", "type": "DRUG" }, { "name": "Best Practice", "type": "OTHER" }, { "name": "Biopsy Procedure", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Marrow Aspiration", "type": "PROCEDURE" }, { "name": "Bone Marrow Biopsy", "type": "PROCEDURE" }, { "name": "Busulfan", "type": "DRUG" }, { "name": "Chest Radiography", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Daunorubicin Hydrochloride", "type": "DRUG" }, { "name": "Decitabine and Cedazuridine", "type": "DRUG" }, { "name": "Echocardiography Test", "type": "PROCEDURE" }, { "name": "Emavusertib", "type": "BIOLOGICAL" }, { "name": "Enasidenib", "type": "DRUG" }, { "name": "Epoetin Alfa", "type": "BIOLOGICAL" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Gemtuzumab Ozogamicin", "type": "DRUG" }, { "name": "Gilteritinib", "type": "DRUG" }, { "name": "Liposome-encapsulated Daunorubicin-Cytarabine", "type": "DRUG" }, { "name": "Luspatercept", "type": "BIOLOGICAL" }, { "name": "Melphalan", "type": "DRUG" }, { "name": "Multigated Acquisition Scan", "type": "PROCEDURE" }, { "name": "Mutation Carrier Screening", "type": "PROCEDURE" }, { "name": "Olutasidenib", "type": "DRUG" }, { "name": "Placebo Administration", "type": "DRUG" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Total-Body Irradiation", "type": "RADIATION" }, { "name": "Venetoclax", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER", "BIOLOGICAL", "RADIATION" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2000, "start_date": "2024-06-18", "completion_date": "2029-05-15", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-09-30T21:12:05.114Z", "location_count": 337, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 260 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05564390" }, { "nct_id": "NCT04298944", "title": "Association of Mood With Risk for Atherosclerosis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Mood Disorders", "Hypertension", "Overweight and Obesity", "Vascular Stiffness", "Sleep", "Elevated Blood Pressure" ], "interventions": [ { "name": "Cardiovascular Assessments", "type": "DIAGNOSTIC_TEST" }, { "name": "Actigraphy", "type": "DIAGNOSTIC_TEST" }, { "name": "Laboratory assessments", "type": "DIAGNOSTIC_TEST" }, { "name": "Emotional/ Behavioural assessments", "type": "BEHAVIORAL" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "BEHAVIORAL" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": null, "maximum_age": "22 Years", "sex": "ALL", "summary": "Up to 22 Years" }, "enrollment_count": 37, "start_date": "2020-03-11", "completion_date": "2022-05-31", "has_results": false, "last_update_posted_date": "2022-08-23", "last_synced_at": "2026-09-30T21:12:05.114Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04298944" } ] }